Anspor – Detailed Drug Information, Uses, Side Effects

Introduction

Anspor is a semi-synthetic cephalosporin Antibiotic” target=”_blank”>antibiotic used to treat various Bacterial_infection” target=”_blank”>bacterial infections. Its active ingredient, Cephradine” target=”_blank”>cephradine, belongs to the beta-lactam class of antibiotics. Anspor acts as a bactericidal agent by inhibiting bacterial cell wall synthesis. It is effective against a wide range of gram-positive and gram-negative bacteria, making it a valuable tool in the Antibiotic” target=”_blank”>treatment of infections in the healthcare field.

Chemical Composition

The chemical name for cephradine is (6R,7R)-7-[(R)-2-amino-2-(1,4-cyclohexadien-1-yl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid. Its molecular formula is C16H19N3O4S, and it has a molecular weight of 349.41 g/mol. Cephradine is a white to off-white crystalline powder that is slightly soluble in water and methanol. The CAS number for cephradine is 38821-53-3.

Pharmacology

Anspor‘s active ingredient, cephradine, inhibits bacterial cell wall synthesis by binding to and inactivating penicillin-binding proteins (PBPs). This disrupts the cross-linking of peptidoglycan, a crucial component of the bacterial cell wall, leading to cell lysis and death. Cephradine is rapidly absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 1 to 2 hours after oral administration. It is primarily excreted unchanged in the urine, with a half-life of approximately 1 hour.

Mode of Action

As a cephalosporin antibiotic, Anspor (cephradine) functions as a bactericidal agent by inhibiting the synthesis of the bacterial cell wall. It specifically binds to and inactivates penicillin-binding proteins (PBPs), enzymes responsible for the cross-linking of peptidoglycan, a major component of the cell wall. By disrupting this process, Anspor weakens the cell wall, leading to cell lysis and death of the bacteria. It is effective against a wide range of gram-positive and gram-negative bacteria, including Streptococcus pyogenes, Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, and Escherichia coli.

Uses and Indications

Anspor is indicated for the treatment of a variety of bacterial infections, including:

• Respiratory tract infections, such as Pharyngitis” target=”_blank”>pharyngitis, Sinusitis” target=”_blank”>sinusitis, Bronchitis” target=”_blank”>bronchitis, and Pneumonia” target=”_blank”>pneumonia
• Skin and soft tissue infections, including Cellulitis” target=”_blank”>cellulitis, erysipelas, and Abscess” target=”_blank”>abscesses
• Urinary tract infections, such as cystitis and Pyelonephritis” target=”_blank”>pyelonephritis
• Ear infections, like otitis media

Brand Names and Manufacturers

Anspor is marketed under various brand names worldwide, including:

• Bactocef (South Africa)
• Broadcef (Korea)
• Cefadin (Taiwan)
• Cefamid
• Eskefrin
• Velosef (United States)

The drug is manufactured by several pharmaceutical companies, such as GlaxoSmithKline, Bristol-Myers Squibb, and Aspen Pharmacare.

Dosage Forms and Administration

Anspor is available in various dosage forms, including:

• Tablets: 250 mg, 500 mg, and 1000 mg
• Capsules: 250 mg and 500 mg
• Oral suspension: 125 mg/5 mL and 250 mg/5 mL

The recommended dosage and duration of treatment depend on the type and severity of the infection, as well as the patient’s age and kidney function. Generally, adults are prescribed 250 mg to 1000 mg every 6 to 12 hours, while children receive 25 to 50 mg/kg/day in divided doses. It is important to follow the healthcare provider’s instructions and complete the entire course of treatment, even if symptoms improve.

Side Effects and Adverse Reactions

Like all medications, Anspor may cause side effects. Common side effects include:

• Nausea and vomiting
• Diarrhea
• Abdominal pain
• Headache
• Skin rash or itching

Serious adverse reactions are rare but may include Anaphylaxis” target=”_blank”>anaphylaxis, Stevens-Johnson syndrome , and pseudomembranous colitis. If any severe symptoms occur, seek immediate medical attention.

Interactions

Anspor may interact with other medications, including:

• Probenecid, which can increase cephradine levels in the body
• Oral contraceptives, as cephradine may reduce their effectiveness
• Nephrotoxic drugs, such as aminoglycosides and loop diuretics, which may increase the risk of kidney damage when used with cephradine

Inform your healthcare provider about all medications, supplements, and herbal products you are taking to avoid potential interactions.

Contraindications and Precautions

Anspor is contraindicated in patients with a known allergy to cephradine or other cephalosporins. It should be used with caution in individuals with a history of allergies, especially to penicillins, as cross-reactivity may occur. Patients with kidney impairment may require dosage adjustments, as cephradine is primarily eliminated through the kidneys. Pregnant and breastfeeding women should only use Anspor if the potential benefits outweigh the risks, as the drug can pass through the placenta and into breast milk.

Clinical Studies and Efficacy

Numerous clinical studies have demonstrated the efficacy of Anspor in treating various bacterial infections. A randomized controlled trial published in the Journal of Clinical Pathology found that cephradine was effective in treating urinary tract infections caused by Escherichia coli and other gram-negative bacteria. Another study in the Journal of International Medical Research showed that cephradine was as effective as amoxicillin in treating acute bronchitis and pneumonia in adults.

Regulatory Status

Anspor (cephradine) has been approved for medical use by various regulatory agencies worldwide, including the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA). It is classified as a prescription drug, meaning it can only be obtained with a valid prescription from a licensed healthcare provider. The drug’s regulatory status may vary depending on the country and local laws.

History and Development

Cephradine was first synthesized in the early 1970s by researchers at Smith, Kline & French Laboratories (now part of GlaxoSmithKline). It was developed as a semi-synthetic cephalosporin antibiotic with a broad spectrum of activity against gram-positive and gram-negative bacteria. Anspor was introduced to the market in the mid-1970s and has since been widely used to treat various bacterial infections in both hospital and community settings.

Comparisons with Other Antibiotics

Anspor belongs to the first-generation cephalosporin class of antibiotics. It has a similar spectrum of activity to other first-generation cephalosporins, such as cephalexin and cefadroxil. However, cephradine may have slightly better activity against certain gram-negative bacteria, such as Escherichia coli. Compared to penicillins, such as Amoxicillin” target=”_blank”>amoxicillin, Anspor may be less effective against some gram-positive bacteria but offers a broader spectrum of coverage against gram-negative organisms.

Patient Information

When prescribed Anspor, patients should follow their healthcare provider’s instructions carefully. Take the medication at regular intervals as directed, and complete the entire course of treatment, even if symptoms improve. Anspor can be taken with or without food; however, taking it with meals may help reduce gastrointestinal side effects. If a dose is missed, take it as soon as possible, unless it is close to the time for the next dose. In that case, skip the missed dose and continue with the regular schedule.